Literature DB >> 21370500

Five-year longitudinal evaluation of quality of life in a cohort of patients with differentiated thyroid carcinoma.

Massimo Giusti1, Giulia Melle, Monica Fenocchio, Lorenzo Mortara, Francesca Cecoli, Valeria Caorsi, Diego Ferone, Francesco Minuto, Elda Rasore.   

Abstract

Differentiated thyroid carcinoma (DTC) generally has a favorable outcome. Thyroid disease, treatments, stress, and comorbidity can compromise health-related quality of life (QoL) and indirectly weigh upon the outcome. From 2004 to 2008, we evaluated QoL longitudinally in 128 DTC subjects. During scheduled examinations, subjects were asked to undergo a semi-structured psychiatric interview and five rated inventories. The same examination was conducted in 219 subjects after surgery for benign thyroid pathology. Low scores represent a better QoL. DTC and control subjects were similar in terms of age, male/female ratio, concomitant psychopharmacological treatments, and frequency of psychiatric diseases. In DTC subjects, Billewicz scale (BS) scores showed an increasing trend over time, especially among females. The ad hoc thyroid questionnaire (TQ) scores were similar in both groups and did not change over time, but at the end of the study ad hoc TQ and BS were significantly related. Ad hoc TQ scores were also related to age on entry to the study. In both male and female DTC subjects, Hamilton's tests for anxiety (HAM-A), but not for depression (HAM-D), showed an improving trend. At the end of the study, HAM-A and HAM-D scores were comparable to those of the control group. HAM-A and HAM-D were both positively correlated with the stage of cancer and the time between diagnosis and treatment. Only HAM-D correlated with age on entry to the study. Kellner symptom questionnaire (KSQ) item scores were higher in DTC subjects than in controls. The change over time in the items including anxiety, somatization, depression, and hostility was significant. Somatization and hostility were more significantly reduced in DTC females than in DTC males. Hostility scores were significantly lower in DTC subjects than in controls at the end of the study. Somatization and depression were significantly related to staging on diagnosis and age on entry to the study. Our study confirms a wide variation of illness perception in DTC subjects, which is generally unrelated to the favorable clinical follow-up of the disease. Psychological evaluation during long-term follow-up improved QoL scores, which reached the same levels noted in subjects with a history of thyroid surgery for benign thyroid pathology. Our data indicate that special attention should be paid to QoL in older DTC subjects and those with more severe staging on diagnosis.

Entities:  

Mesh:

Year:  2011        PMID: 21370500      PMCID: PMC3048930          DOI: 10.1631/jzus.B1000382

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  32 in total

1.  A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal.

Authors:  Pamela R Schroeder; Bryan R Haugen; Furio Pacini; Christoph Reiners; Martin Schlumberger; Steven I Sherman; David S Cooper; Kathryn G Schuff; Lewis E Braverman; Monica C Skarulis; Terry F Davies; Ernest L Mazzaferri; Gilbert H Daniels; Douglas S Ross; Markus Luster; Mary H Samuels; Bruce D Weintraub; E Chester Ridgway; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2006-01-04       Impact factor: 5.958

2.  Health-related quality of life in thyroid cancer survivors.

Authors:  Lincoln G L Tan; Luo Nan; Julian Thumboo; Felix Sundram; Luke K S Tan
Journal:  Laryngoscope       Date:  2007-03       Impact factor: 3.325

3.  Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study.

Authors:  D Taïeb; F Sebag; M Cherenko; K Baumstarck-Barrau; C Fortanier; B Farman-Ara; C De Micco; J Vaillant; S Thomas; B Conte-Devolx; A Loundou; P Auquier; J F Henry; O Mundler
Journal:  Clin Endocrinol (Oxf)       Date:  2008-09-18       Impact factor: 3.478

4.  Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.

Authors:  Jandee Lee; Mee Jin Yun; Kee Hyun Nam; Woong Youn Chung; Euy-Young Soh; Cheong Soo Park
Journal:  Thyroid       Date:  2010-02       Impact factor: 6.568

Review 5.  Contemporary post surgical management of differentiated thyroid carcinoma.

Authors:  H Tala; R M Tuttle
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-06-01       Impact factor: 4.126

6.  Quality of life in cured patients with differentiated thyroid carcinoma.

Authors:  Hendrieke C Hoftijzer; Karen A Heemstra; Eleonora P M Corssmit; Agatha A van der Klaauw; Johannes A Romijn; Johannes W A Smit
Journal:  J Clin Endocrinol Metab       Date:  2007-10-23       Impact factor: 5.958

Review 7.  Understanding the relationship between age and thyroid cancer.

Authors:  Megan R Haymart
Journal:  Oncologist       Date:  2009-03-06

8.  Clinical predictors of quality of life in patients with initial differentiated thyroid cancers.

Authors:  Juliana Pereira Almeida; Juliana Almeida; José Guilherme Vartanian; Luiz Paulo Kowalski
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-04

9.  Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO.

Authors:  Torquil Watt; Laszlo Hegedüs; Mogens Groenvold; Jakob Bue Bjorner; Ase Krogh Rasmussen; Steen Joop Bonnema; Ulla Feldt-Rasmussen
Journal:  Eur J Endocrinol       Date:  2009-10-01       Impact factor: 6.664

10.  Illness perception in patients with differentiated epithelial cell thyroid cancer.

Authors:  Dania Hirsch; Michal Ginat; Sigal Levy; Carlos Benbassat; Ruth Weinstein; Gloria Tsvetov; Joelle Singer; Ilana Shraga-Slutzky; Simona Grozinski-Glasberg; Yossi Mansiterski; Ilan Shimon; Rivka Reicher-Atir
Journal:  Thyroid       Date:  2009-05       Impact factor: 6.568

View more
  8 in total

1.  Quality of life-in patients with differentiated thyroid cancer at the general endocrinology clinics of the University Hospital of Puerto Rico.

Authors:  Mónica A Vega-Vázquez; Loida Gonzalez-Rodriguez; Eduardo J Santiago-Rodríguez; Anette Garcés-Domínguez; Lee-Ming Shum; Maribel Tírado-Gómez; Margarita Ramírez-Vick
Journal:  Bol Asoc Med P R       Date:  2015 Jan-Mar

2.  Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre.

Authors:  M Giusti; V Caorsi; L Mortara; M Caputo; E Monti; M Schiavo; M C Bagnara; F Minuto; M Bagnasco
Journal:  Endocrine       Date:  2013-04-26       Impact factor: 3.633

3.  Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis.

Authors:  L Mortara; G Pera; E Monti; S Morbelli; F Minuto; G Sambuceti; M Giusti
Journal:  J Endocrinol Invest       Date:  2014-10-05       Impact factor: 4.256

4.  A comparative cross-sectional study on sleep quality in patients with a history of differentiated thyroid carcinoma and its correlation with quality of life.

Authors:  Marsida Teliti; Eleonora Monti; Martina Comina; Lucia Conte; Lara Vera; Stefano Gay; Giorgia Saccomani; Diego Ferone; Massimo Giusti
Journal:  Endocrine       Date:  2021-02-03       Impact factor: 3.633

5.  TSH Variability of Patients Affected by Differentiated Thyroid Cancer Treated with Levothyroxine Liquid Solution or Tablet Form.

Authors:  Carlo Cappelli; Ilenia Pirola; Elena Gandossi; Claudio Casella; Davide Lombardi; Barbara Agosti; Fiorella Marini; Andrea Delbarba; Maurizio Castellano
Journal:  Int J Endocrinol       Date:  2017-05-09       Impact factor: 3.257

Review 6.  Quality of life in thyroid cancer patients: a literature review.

Authors:  Elena Bãrbuş; Claudiu Peştean; Maria Iulia Larg; Doina Piciu
Journal:  Clujul Med       Date:  2017-04-25

7.  Systematic review of health-related quality of life following thyroid cancer.

Authors:  Emma G Walshaw; Mike Smith; Dae Kim; Jonathan Wadsley; Anastasios Kanatas; Simon N Rogers
Journal:  Tumori       Date:  2021-08-13

8.  Evaluation of Quality of Life in Patients with Differentiated Thyroid Cancer by Means of the Thyroid-Specific Patient-Reported Outcome Questionnaire: A 5-Year Longitudinal Study.

Authors:  Massimo Giusti; Stefano Gay; Lucia Conte; Francesca Cecoli; Lorenzo Mortara; Lara Vera; Eleonora Monti
Journal:  Eur Thyroid J       Date:  2019-07-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.